EP 1859801 A4 20090211 - THERAPEUTIC AGENT AND PROPHYLACTIC AGENT FOR ENDOMETRIOSIS AND ADENOMYOSIS UTERI
Title (en)
THERAPEUTIC AGENT AND PROPHYLACTIC AGENT FOR ENDOMETRIOSIS AND ADENOMYOSIS UTERI
Title (de)
THERAPEUTISCHES MITTEL UND PROPHYLAKTISCHES MITTEL GEGEN ENDOMETRIOSE UND ADENOMYOSIS UTERI
Title (fr)
AGENT THERAPEUTIQUE ET AGENT PROPHYLACTIQUE POUR L'ENDOMETRIOSE ET L ADENOMYOSE DE L UTERUS
Publication
Application
Priority
- JP 2006305136 W 20060315
- JP 2005075735 A 20050316
Abstract (en)
[origin: EP1859801A1] An object of the present invention is to provide an agent for use in the effective treatment and prevention of endometriosis and uterine adenomyosis. The present invention relates to an agent for use in the treatment and prevention of endometriosis or uterine adenomyosis, comprising, as an active ingredient, a compound selected from the group consisting of 3-ethylpyridine, 3-methylpyridine, 2-ethylpyridine, and 2-methylpyridine.
IPC 8 full level
A61K 31/4402 (2006.01); A61K 31/4406 (2006.01); A61K 31/58 (2006.01); A61P 15/00 (2006.01)
CPC (source: EP US)
A61K 31/4402 (2013.01 - EP US); A61K 31/4406 (2013.01 - EP US); A61K 31/58 (2013.01 - EP US); A61P 15/00 (2017.12 - EP)
Citation (search report)
- No further relevant documents disclosed
- See references of WO 2006098371A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
EP 1859801 A1 20071128; EP 1859801 A4 20090211; EP 1859801 B1 20120801; JP 5020811 B2 20120905; JP WO2006098371 A1 20080828; US 2008182830 A1 20080731; US 7705011 B2 20100427; WO 2006098371 A1 20060921
DOCDB simple family (application)
EP 06729157 A 20060315; JP 2006305136 W 20060315; JP 2007508184 A 20060315; US 88623406 A 20060315